Conference Proceedings
Granzyme a deficiency breaks immune tolerance and promotes autoimmune diabetes through a Type i interferon-dependent pathway
ZUA Mollah, HS Quah, KL Graham, G Jhala, B Krishnamurthy, JFM Dharma, J Chee, PM Trivedi, EG Pappas, L Mackin, EPF Chu, S Akazawa, S Fynch, C Hodson, AJ Deans, JA Trapani, MMW Chong, PI Bird, TC Brodnicki, HE Thomas Show all
Diabetes | AMER DIABETES ASSOC | Published : 2017
DOI: 10.2337/db17-0517
Abstract
Granzyme A is a protease implicated in the degradation of intracellular DNA. Nucleotide complexes are known triggers of systemic autoimmunity, but a role in organ-specific autoimmune disease has not been demonstrated. To investigate whether such a mechanism could be an endogenous trigger for autoimmunity, we examined the impact of granzyme A deficiency in the NOD mouse model of autoimmune diabetes. Granzyme A deficiency resulted in an increased incidence in diabetes associated with accumulation of ssDNA in immune cells and induction of an interferon response in pancreatic islets. Central tolerance to proinsulin in transgenic NOD mice was broken on a granzyme A-deficient background. We have i..
View full abstractRelated Projects (1)
Grants
Awarded by Juvenile Diabetes Research Foundation United States of America
Funding Acknowledgements
This work was funded by a National Health and Medical Research Council of Australia (NHMRC) program grant (APP1037321), an NHMRC and JDRF joint special program grant in type 1 diabetes (APP466658), and fellowships from the JDRF (Z.U.A.M. and B.K.) and NHMRC (M.M.W.C. and H.E.T.). This work received support from the Operational Infrastructure Support Scheme of the Government of Victoria.